The US Food and Drug Administration (FDA) is stepping up its regulatory endeavors with draft guidance for cosmetic manufacturing facility registration and cosmetic product listings. The recent draft is specifically designed to assist the “responsible persons” that are required to submit these registrations and listings under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA).
This comes as a significant development for any organization involved in cosmetics manufacturing or private labeling. As indicated by Morgan Lewis, every cosmetic manufacturer and private labeler will be required to make a submission under this new draft guidance. This requirement serves as a new foundation mandating industry participation, irrespective of any involvement in previous voluntary registration programs.
Further details on the draft guidance or the specifics of the submission requirements have not been disclosed at the time of writing this piece. However, all concerned stakeholders can expect to receive more comprehensive information ahead of the deadline set for December 29.
Given the vast changes the MoCRA introduces, cosmetics manufacturers and labelers must stay updated on forthcoming details on the registration and listing requirements. This will help ensure timely compliance and minimize any hindrances in regular operations due to regulatory challenges.
Law firms and legal professionals working closely with cosmetic manufacturers and labelers should monitor these regulatory changes. Providing the necessary guidance and stringently following the timelines will be crucial in making the transition towards the new foundation of cosmetic regulation.